目的探讨介入治疗肝海绵状血管瘤的栓塞剂用量。方法超选择性肝动脉插管平阳霉素碘化油乳剂(PLE)栓塞治疗肝海绵状血管瘤40例,根据栓后瘤周有无碘油进入分为2组。对比观察2组药物用量、疗效、并发症。结果2组有效率无显著差异,药物用量、持续性疼痛发生率碘油进入门静脉组均高于对照组。结论CHL栓塞治疗中,栓塞剂用量应以个体化原则,以不出现瘤周门静脉碘油进入为宜。 Objective To investigate the interventional treatment of hepatic cavernous hemangioma embolization dosage. Methods Forty patients with hepatic cavernous hemangiomas were treated with trans-selective hepatic arterial infusion of pingyangmycin iodinated oil emulsion (PLE). According to the presence or absence of lipiodol, the patients were divided into two groups. Compare two groups of drug dosage, efficacy, complications. The results of two groups no significant difference in the efficiency, drug dosage, the incidence of persistent pain lipiodol into the portal vein group were higher than the control group. Conclusions In the treatment of CHL embolism, the amount of embolic agent should be based on the principle of individuation, so as to prevent the entry of tumorous portal vein lipiodol.